CINECA IRIS Institutional Research Information System

Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms

Saglio, Giuseppe;
2018-01-01
2018
HEMATOLOGICAL ONCOLOGY
36
5
740
748
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1069
Chronic myeloroliferative neoplasms; genomics; immunotherapy; treatment; Amino Acid Substitution; Fusion Proteins, bcr-abl; Humans; Immunotherapy; Janus Kinase 2; Mutation, Missense; Precision Medicine; Translational Medical Research; Hematologic Neoplasms; Myeloproliferative Disorders; Hematology; Oncology; Cancer Research
Mughal, Tariq I.*; Lion, Thomas; Abdel-Wahab, Omar; Mesa, Ruben; Scherber, Robyn M.; Perrotti, Danilo; Mauro, Michael; Verstovsek, Srdan; Saglio, Giuseppe; Van Etten, Richard A.; Kralovics, Robert
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
paper2.docx

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 145.69 kB
Formato Microsoft Word XML
Visualizza/Apri
145.69 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1701784
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact